DG

David Gill

Telix Pharmaceuticals Limited | Non-Executive Director, Non-Executive Chairman
Mr. Gill is a life sciences executive with 35 years' experience in senior general management and financial leadership roles across commercial and clinical-stage biopharmaceutical. Mr. Gill serves on the boards of Evolus, Inc. (NASDAQ: EOLS), Allucent LLC, Bridge to Life Ltd, RapidPulse Inc., and huMannity Medtec.

Company and Roles

Company
Title
Tenure
Since
TLX
TLX
Telix Pharmaceuticals Limited
  • Non-Executive Director
  • Non-Executive Chairman
5mthMay 2026

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
TLX
TLX
Telix Pharmaceuticals Limited
23/10/2625,250N/AN/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
TLX
TLX
Telix Pharmaceuticals Limited
23/10/26
Buy
3,250$9.194$29,880On-market trade
TLX
TLX
Telix Pharmaceuticals Limited
24/09/26
Buy
11,800$11.310$133,458On-market trade
TLX
TLX
Telix Pharmaceuticals Limited
11/06/26
Buy
10,200$9.433$96,221On-market trade
TLX
TLX
Telix Pharmaceuticals Limited
26/05/26
Issued
30,048$13.230$397,535Issue of securities